furthermore , the polysaccharide antigen in the polyvalent pneumococcal vaccine reacted to form precipitation lines with antisera directed against type-14 pneumococcus and group-b streptococcus type iii immunisation with currently available pneumococcal vaccine may provide opsonic antibody against group-b streptococci and provide a method of preventing neonatal group-b streptococcal infections .
C0020960
antisera
C0003241
antibody